PERFUSION INDEX, PRONE ,SUPİNE AND SITTING POSITION
OBESE PATIENTS AND ANAESTHESİA İNDUCTİON: PERFUSION INDEX, PRONE ,SUPİNE AND SITTING POSITION
Study Overview
Status
Status
Conditions
Conditions
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Contacts and Locations
Study Locations
-
-
-
Amasya, Turkey, 05100
- Amasya University Hospital
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- 18-70 years range
- Patients who will be operated in supine prone and sitting positions
Exclusion Criteria:
- Heart Failure
- antiarrhythmic drug use hemodynamic instability uncooperative patients
Study Plan
How is the study designed?
Design Details
Number of groups / cohorts
Cohorts and Interventions
Group / CohortGroup / Cohort |
|---|
|
gruops
patient supine position
|
|
groupp
patient prone position
|
|
grupsitting
patient sitting position
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Group P-S-ST
Time Frame: preoperative 5 minute and after anesthesia induction 10 20 30. mimute Perfusion İndex value)
|
Comparison after anesthesia induction in prone, supine and sitting positions.(Perfusion
index value)
|
preoperative 5 minute and after anesthesia induction 10 20 30. mimute Perfusion İndex value)
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Body mass index, age,comorbidities
Time Frame: preoperative perion (10 minutes before anesthesia)
|
in preoperative period patiens body mass index (kg/m2), age (years) and comorbidities were recorded
|
preoperative perion (10 minutes before anesthesia)
|
Collaborators and Investigators
Sponsor
Sponsor
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
Other Study ID Numbers
- u1103
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.